Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices 29769 

requirements of the applicable statutes 

and regulations. 

II. Paperwork Reduction Act of 1995 

This guidance refers to previously 

approved collections of information 

found in FDA regulations. These 

collections of information are subject to 

review by the Office of Management and 

Budget (OMB) under the Paperwork 

Reduction Act of 1995 (44 U.S.C. 3501– 

3520). The collections of information in 

21 CFR 601.12 have been approved 

under OMB control number 0910–0338; 

the collections of information in 21 CFR 

606.100 have been approved under 

OMB control number 0910–0116; and 

the collections of information in 21 CFR 

Part 600.14 and 606.171 have been 

approved under OMB control number 

0910–0458. 

III. Comments 

Interested persons may, at any time, 

submit to the Division of Dockets 

Management (see ADDRESSES) electronic 

or written comments regarding the 

guidance. Submit a single copy of 

electronic comments or two paper 

copies of any mailed comments, except 

that individuals may submit one paper 

copy. Comments are to be identified 

with the docket number found in 

brackets in the heading of this 

document. A copy of the guidance and 

received comments are available for 

public examination in the Division of 

Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

IV. Electronic Access 

Persons with access to the Internet 

may obtain the guidance at either http:// 

www.fda.gov/BiologicsBloodVaccines/ 

GuidanceComplianceRegulatory

Information/Guidances/default.htm or 

http://www.regulations.gov. 

Dated: May 18, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–12696 Filed 5–26–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meetings 

In accordance with section 10(d) of 

the Federal Advisory Committee Act as 

amended (5 U.S.C., Appendix 2), the 

Agency for Healthcare Research and 

Quality (AHRQ) announces meetings of 

scientific peer review groups. The 

subcommittees listed below are part of 

the Agency’s Health Services Research 

Initial Review Group Committee. 

The subcommittee meetings will be 

closed to the public in accordance with 

the Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications are to be reviewed and 

discussed at these meetings. These 

discussions are likely to involve 

information concerning individuals 

associated with the applications, 

including assessments of their personal 

qualifications to conduct their proposed 

projects. This information is exempt 

from mandatory disclosure under the 

above-cited statutes. 

1. Name of Subcommittee: Health Care 

Technology and Decision Sciences. 

Date: June 15–17, 2010 (Open from 8 a.m. 

to 8:15 a.m. on June 15 and closed for 

remainder of the meeting) 

Place: Crowne Plaza Hotel, 3 Research 

Court, Conference Room TBD, Rockville, MD 

20852. 

2. Name of Subcommittee: Health Systems 

Research. 

Date: June 16–18, 2010 (Open from 8 a.m. 

to 8:15 a.m. on June 16 and closed for 

remainder of the meeting) 

Place: Sheraton Rockville Hotel, 920 King 

Farm Boulevard, Conference Room TBD, 

Rockville, MD 20852. 

3. Name of Subcommittee: Health Care 

Research Training. 

Date: June 17–18, 2010 (Open from 8 a.m. 

to 8:15 a.m. on June 17 and closed for 

remainder of the meeting) 

Place: Hyatt Regency Hotel, 7400 

Wisconsin Avenue, 1 Bethesda Metro Center, 

Conference Room TBD, Bethesda, Maryland 

20814. 

4. Name of Subcommittee: Health Care 

Quality and Effectiveness Research. 

Date: June 22–24, 2010 (Open from 8:30 

a.m. to 8:45 a.m. on June 22 and closed for 

remainder of the meeting) 

Place: Hilton Rockville Executive Meeting 

Center, 1750 Rockville Pike, Conference 

Room TBD, Rockville, Maryland 20850. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of the meetings 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Suite 

2000, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for these meetings are 

subject to change as priorities dictate. 

Dated: May 13, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–12547 Filed 5–26–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Integrating 

Patient-Reported Outcomes in Hospice and 

Palliative Care Practices. 

Date: June 1, 2010. 

Time: 11 a.m. to 2 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Cancer Institute, 6116 

Executive Blvd., Room 8018, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Shamala K. Srinivas, PhD, 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8123, 

Bethesda, MD 20892, 301–594–1224, 

ss537t@nih.gov. 

This notice is being published less than 30 

days prior to the meeting due to scheduling 

conflicts. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Development of Anticancer Agents. 

Date: June 2, 2010. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 8018, Rockville, 

MD 20852 (Telephone Conference Call). 

Contact Person: Joyce C. Pegues, B.S., B.A., 

PhD, Scientific Review Officer, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Boulevard, 

Room 7149, Bethesda, MD 20892–8329, 

301–594–1286, peguesj@mail.nih.gov. 

This notice is being published less than 30 

days prior to the meeting due to scheduling 

conflicts. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 


wwoods2 on DSK1DXX6B1PROD with NOTICES